
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| home:symptoms:gastrointestinal [03.13.2019] – [Bleeding from bowel] sallieq | home:symptoms:gastrointestinal [09.14.2022] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 62: | Line 62: | ||
| ==== Further researxh ==== | ==== Further researxh ==== | ||
| - | Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. | + | Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. |
| - | In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. | + | In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. |
| + | < | ||
| ===== Notes and comments ===== | ===== Notes and comments ===== | ||
| - | ===== References ===== | + | ===== References =====</ |